title: I.v. therapy: the legislative and regulatory arena.
abstract: The inclusion of home IV drug therapy in the Medicare Catastrophic Coverage Act of 1988 brought IV therapy issues to the attention of regulators and providers. Although the legislation was revoked, the issues that were raised in its development must be addressed under the current programs and in any future home IV therapy legislation.
authors: National Association of Home Care, Washington, DC.
authors: C
authors: C
authors: Hughes
authors: D
authors: D
authors: Berke
mesh_terms: D000368:Aged; D002388:Catastrophic Illness / Q000191:economics; D014487:Centers for Medicare and Medicaid Services, U.S.; D002568:Certification / Q000331:legislation & jurisprudence*; D006699:Home Care Services / Q000191:economics*; D006801:Humans; D007262:Infusions, Intravenous / Q000191:economics*; D006278:Medicare; D014481:United States